ArticleApplied and environmental microbiology2025
Development of poly-D-mannose-stabilized silver nanoparticles exhibiting antibacterial and antibiofilm properties.
Article in Applied and environmental microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In this study, previously synthesized poly-D-mannose (PM) served as the stabilizing agent for the production of silver nanoparticles (designated PM-AgNPs), which were subsequently assessed for their antibacterial and antibiofilm capabilities against foodborne pathogens. The PM-AgNPs were successfully synthesized, exhibiting a distinct surface plasmon resonance absorption peak at 400 nm. Fourier transform infrared analysis revealed the stabilization mechanism of silver nanoparticles by PM, involving the formation of O-H⋯Ag hydrogen bonds and C-O⋯Ag coordination bonds. Both transmission electron microscopy and dynamic light scattering measurements confirmed the spherical morphology of PM-AgNPs, with particle sizes ranging from 2 to 18 nm and a zeta potential of -24.7 mV. Furthermore, energy-dispersive X-ray spectroscopy analysis disclosed the elemental composition of PM-AgNPs to be C:O:Ag in a ratio of 39.32:37.93:22.75. To evaluate the antibacterial and antibiofilm efficacy of PM-AgNPs against selected pathogenic bacteria and their biofilms, the broth microdilution method and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide staining assay were employed, respectively. The inhibitory effect of PM-AgNPs on five pathogenic bacteria was found to be in the following order: IMPORTANCE: The control of foodborne pathogens, including
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.